 | Up a level |
Oppliger Leibundgut, Elisabeth; Haubitz, Monika; Burington, Bart; Ottmann, Oliver G; Spitzer, Gary; Odenike, Olatoyosi; McDevitt, Michael A; Röth, Alexander; Snyder, David S; Baerlocher, Gabriela M. (2021). Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat. Haematologica - the hematology journal, 106(9), pp. 2397-2404. Ferrata-Storti Foundation 10.3324/haematol.2020.252817
Baerlocher, Gabriela M.; Haubitz, Monika; Braschler, Thomas R; Brunold, Claudio; Burington, Bart; Oppliger Leibundgut, Elisabeth; Go, Ning (2019). Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia. Blood advances, 3(22), pp. 3724-3728. American Society of Hematology 10.1182/bloodadvances.2019000167
Baerlocher, Gabriela M.; Burington, Bart; Snyder, David S (2015). Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis. New England journal of medicine NEJM, 373(26), p. 2580. Massachusetts Medical Society MMS 10.1056/NEJMc1512663
Baerlocher, Gabriela M.; Oppliger Leibundgut, Elisabeth; Ottmann, Oliver G; Spitzer, Gary; Odenike, Olatoyosi; McDevitt, Michael A; Röth, Alexander; Daskalakis, Michael; Burington, Bart; Stuart, Monic; Snyder, David S (2015). Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. New England journal of medicine NEJM, 373(10), pp. 920-928. Massachusetts Medical Society MMS 10.1056/NEJMoa1503479
